In the past four trading days, the stock has surged 17 per cent. In the past four months, it has zoomed nearly 90 per cent. Further, in the past one year, the stock of the drug maker has seen its market price more-than-double (up 102 per cent), as compared to a 2 per cent rise in the S&P BSE Sensex.
Stock of this pharma company has zoomed nearly 90% in last four months
In the past three months, Unichem Labs has received abbreviated new drug application (ANDA) approvals for four drugs from the United States Food and Drug Administration (USFDA)
 "Unichem Laboratories")
Premium
Unichem Laboratories. Photo: UnichemLabs.com
In the past four trading days, the stock has surged 17 per cent. In the past four months, it has zoomed nearly 90 per cent. Further, in the past one year, the stock of the drug maker has seen its market price more-than-double (up 102 per cent), as compared to a 2 per cent rise in the S&P BSE Sensex.
First Published: Nov 03 2022 | 12:11 PM IST
Key stories on business-standard.com are available only to BS Premium subscribers.
Register to read more on Business-Standard.com
